Search Articles

Using the Technology Acceptance Model to Explore User Experience, Intent to Use, and Use Behavior of a Patient Portal Among Older Adults With Multiple Chronic Conditions: Descriptive Qualitative Study

Jennifer Dickman Portz, Elizabeth A Bayliss, Sheana Bull, Rebecca S Boxer, David B Bekelman, Kathy Gleason, Sara Czaja

J Med Internet Res 2019;21(4):e11604

Download Citation: END BibTex RIS

Prostate Cancer Risk Calculator Apps in a Taiwanese Population Cohort: Validation Study

Prostate cancer (PCa) risk calculator mobile apps have been introduced to assess risks of PCa and high-grade PCa (Gleason score ≥7).

I-Hsuan Alan Chen, Chi-Hsiang Chu, Jen-Tai Lin, Jeng-Yu Tsai, Chia-Cheng Yu, Ashwin Narasimha Sridhar, Prasanna Sooriakumaran, Rui C V Loureiro, Manish Chand

J Med Internet Res 2020;22(12):e16322

Download Citation: END BibTex RIS

“Call a Teenager… That’s What I Do!” - Grandchildren Help Older Adults Use New Technologies: Qualitative Study

Jennifer Dickman Portz, Christine Fruhauf, Sheana Bull, Rebecca S Boxer, David B Bekelman, Alejandra Casillas, Kathy Gleason, Elizabeth A Bayliss

JMIR Aging 2019;2(1):e13713

Download Citation: END BibTex RIS

Improving Care in the Pediatric Emergency Department With Virtual Reality

Cotten cotten@msu.eduJul-Dec20181709201842e117962820182982018©Jessica DeClercq, Marie Bowen, Shelia R Cotten, Aileen Hansen, Kelly Hebert, Jodi Nohel, Kristin Weber, Karl Engler, Kathy Marble.

Jessica DeClercq, Marie Bowen, Shelia R. Cotten, Aileen Hansen, Kelly Hebert, Jodi Nohel, Kristin Weber, Karl Engler, Kathy Marble

iproc 2018;4(2):e11796

Download Citation: END BibTex RIS

Confocal Laser Endomicroscopy and Optical Coherence Tomography for the Diagnosis of Prostate Cancer: A Needle-Based, In Vivo Feasibility Study Protocol (IDEAL Phase 2A)

The atlas will differentiate prostate tissues including benign glands, cystic atrophy, regular atrophy, stroma, inflammation, fat as well as different grades of malignant tissue using the Gleason score.

Abel Swaan, Christophe K Mannaerts, Matthijs J V Scheltema, Jakko A Nieuwenhuijzen, C Dilara Savci-Heijink, Jean J M C H de la Rosette, R Jeroen A van Moorselaar, Ton G van Leeuwen, Theo M de Reijke, Daniel Martijn de Bruin

JMIR Res Protoc 2018;7(5):e132

Download Citation: END BibTex RIS

Development, Feasibility, and Small-Scale Implementation of a Web-Based Prognostic Tool—Surveillance, Epidemiology, and End Results Cancer Survival Calculator

In addition, SEER should be explained on the output pages for those that skip the home page and move right to the calculators.Prostate disease characteristicsConcerns were raised about the appropriateness of selected categories for Gleason score.

Michelle Henton, Bridget Gaglio, Laurie Cynkin, Eric J Feuer, Borsika A Rabin

JMIR Cancer 2017;3(2):e9

Download Citation: END BibTex RIS

Characterizing Artificial Intelligence Applications in Cancer Research: A Latent Dirichlet Allocation Analysis

complications; length; hospital; min; postoperative; conversion; perioperative; complication; safe; intraoperative; feasible17.165050 (41.13)5Prostate; assisted radicalProstatectomy; prostate; radical; RARPa; localized; men; assisted; radical prostatectomy; robot; Gleason

Bach Xuan Tran, Carl A Latkin, Noha Sharafeldin, Katherina Nguyen, Giang Thu Vu, Wilson W S Tam, Ngai-Man Cheung, Huong Lan Thi Nguyen, Cyrus S H Ho, Roger C M Ho

JMIR Med Inform 2019;7(4):e14401

Download Citation: END BibTex RIS

A Multimedia Child Developmental Screening Checklist: Design and Validation

Hsin-Yi Kathy Cheng, Li-Ying Chen, Chih-Hsiu Cheng, Yan-Ying Ju, Chia-Ling Chen, Kevin C Tseng

J Med Internet Res 2016;18(10):e277

Download Citation: END BibTex RIS

Rotterdam Prostate Cancer Risk Calculator: Development and Usability Testing of the Mobile Phone App

extensively validated risk calculator is the Rotterdam Prostate Cancer Risk Calculator (RPCRC), based on the ERSPC Rotterdam data [9].The RPCRC predicts the risk of a biopsy-detectable prostate cancer and also of potentially high-risk prostate cancer, defined as Gleason

Nuno Pereira-Azevedo, Luís Osório, Avelino Fraga, Monique J Roobol

JMIR Cancer 2017;3(1):e1

Download Citation: END BibTex RIS

Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol

Recently, active surveillance (AS) has been advocated for selected low-risk cancers with the recognition that Gleason 6 disease is rarely a cause of cancer mortality.

Ana Fernandez Ots, Joseph Bucci, Yaw Sinn Chin, David Malouf, Andrew Howie, Komiti Ese Enari

JMIR Res Protoc 2016;5(2):e98

Download Citation: END BibTex RIS